SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-08-028372
Filing Date
2008-12-19
Accepted
2008-12-19 16:33:34
Documents
1
Period of Report
2008-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4690
  Complete submission text file 0001140361-08-028372.txt   6804
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 509 MADISON AVE 14TH FL NEW YORK NY 10022
Business Address DISCOVERY LABORATORIES INC 509 MADISON AVE 14TH FLOOR NEW YORK NY 10022 2122234504
MYRIANTHOPOULOS EVAN (Reporting) CIK: 0001050955 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 081261481